Tanzania recently reported its first two mpox cases, raising the number of affected countries to 23, officials from the ...
Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Health Minister Jenista Mhagama declared Marburg over six weeks after the last case in Kagera's Biharamulo district, where two died.
A new mutated variant of Mpox has been identified in Democratic Republic of Congo, with health authorities concerned over ...
Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...
A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.
The two confirmed infected individuals have symptoms such as rash, fever, and headache, as well as pain in the body and ...
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback